These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3538252)

  • 21. Tocainide for arrhythmias.
    Med Lett Drugs Ther; 1985 Feb; 27(680):9-11. PubMed ID: 3918240
    [No Abstract]   [Full Text] [Related]  

  • 22. [Perspectives in anti-arrhythmia pharmacological therapy].
    Furlanello F; Vergara G; Inama G; Dal Forno P; Bettini R; Disertori M
    Cardiologia; 1984; 29(1-2):73-84. PubMed ID: 6442869
    [No Abstract]   [Full Text] [Related]  

  • 23. Are implantable cardioverter-defibrillators or drugs more effective in prolonging life? The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial Executive Committee.
    Am J Cardiol; 1997 Mar; 79(5):661-3. PubMed ID: 9068527
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bunaftine in the treatment of arrhythmias].
    Vegis D
    Cardiol Prat; 1975; 26(1):29-36. PubMed ID: 769979
    [No Abstract]   [Full Text] [Related]  

  • 25. [Nadolol in the treatment of arrhythmia].
    Goch JH; Dziekański S; Tkaczewski W
    Wiad Lek; 1984 Mar; 37(5):329-33. PubMed ID: 6382802
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current aspects of anti-arrhythmia therapy].
    Furlanello F
    G Ital Cardiol; 1977; 7(10):935-9. PubMed ID: 924056
    [No Abstract]   [Full Text] [Related]  

  • 27. [Propafenone--a new antiarrhythmic agent. Clinical experience].
    Kozák P; Stárek A; Hes I; Spacek R
    Cas Lek Cesk; 1985 Mar; 124(13):407-10. PubMed ID: 3891090
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug treatment of cardiac arrhythmias. II. Mechanism of formation. Clinical and therapeutic aspects].
    Pasini U
    Arq Bras Cardiol; 1970 Apr; 23(2):121-30. PubMed ID: 5523885
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical evaluation of the anti-arrhythmia effect of trimecaine].
    Merzon AK; Doviner AD; Degtiar AN; Rodin IN; Rudenko NN
    Vrach Delo; 1983 May; (5):23-6. PubMed ID: 6192593
    [No Abstract]   [Full Text] [Related]  

  • 30. [The principles of pharmacotherapy for arrhythmia at the turn of the millenium].
    Fazekas T; Liszkai G
    Orv Hetil; 1999 Dec; 140(51):2851-9. PubMed ID: 10647274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-arrhythmia drugs--administration and effectiveness].
    Odenthal HJ; Wiechmann HW
    Med Monatsschr Pharm; 1987 Dec; 10(12):375-80. PubMed ID: 3325785
    [No Abstract]   [Full Text] [Related]  

  • 32. [Difficulties in the diagnosis and treatment of combined cardiac arrhythmias].
    Doshchitsin VL
    Klin Med (Mosk); 1988 Jan; 66(1):8-14. PubMed ID: 3361821
    [No Abstract]   [Full Text] [Related]  

  • 33. [Is adenosine used effectively in clinical practice?].
    Fiala M
    Vnitr Lek; 2003 Apr; 49(4):251-2. PubMed ID: 12793042
    [No Abstract]   [Full Text] [Related]  

  • 34. Update on new antiarrhythmic drugs.
    Morton PG
    Crit Care Nurs Clin North Am; 1994 Mar; 6(1):69-83. PubMed ID: 8192885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of supraventricular tachyarrhythmias: drugs or ablation?].
    Chimienti M; Barbieri S
    G Ital Cardiol; 1996 Feb; 26(2):213-26. PubMed ID: 8666179
    [No Abstract]   [Full Text] [Related]  

  • 36. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?].
    Naccarella F; Croci F
    G Ital Cardiol; 1996 Nov; 26(11):1345-64. PubMed ID: 9036037
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical experiences with an antiarrhythmic drug combination].
    Klinnert U
    Med Welt; 1972 Dec; 23(49):1878-80. PubMed ID: 4566977
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antiarrhythmic agents: current situation].
    Bonhorst D
    Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ethical problems posed by protocols of studies of anti-arrhythmia agents].
    Nicolas G
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():97-101. PubMed ID: 6803708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.